Olaratumab

Tax included
Olaratumab (IMC-3G3; LY3012207) is an anti-platelet-derived growth factor receptor alpha (PDGFRα) human monoclonal IgG1 antibody with antitumor activity.
MedChemExpress 
HY-P9922

Data sheet

Size
Multiple sizes
Reactivity
PDGFR
Application
Cancer-Kinase/protease
CAS
1024603-93-7